(Q48681712)

14 February 2018

title

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease (English)

1 reference

14 February 2018

positron emission tomography

main subject

Alzheimer's disease

0 references

patient

0 references

1 reference

M Iyo

1

1 reference

14 February 2018

H Namba

2

1 reference

14 February 2018

K Fukushi

3

1 reference

14 February 2018

H Shinotoh

4

1 reference

14 February 2018

S Nagatsuka

5

1 reference

14 February 2018

T Suhara

6

1 reference

14 February 2018

Y Sudo

7

1 reference

14 February 2018

K Suzuki

8

1 reference

14 February 2018

T Irie

9

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

published in

The Lancet

1 reference

14 February 2018

volume

349

1 reference

14 February 2018

issue

9068

1 reference

14 February 2018

page(s)

1805-1809

1 reference

14 February 2018

describes a project that uses

positron emission tomography

1 reference

Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Presynaptic cholinergic dysfunction in patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Cortical biopsy results in Alzheimer's disease: correlation with cognitive deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

In vivo imaging of human cerebral acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

1 reference

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

The diagnosis of dementia with single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Quantifying brain tumor blood flow by the microsphere model with N-isopropyl-p-[123I]iodoamphetamine super-early SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909124-6

7 January 2021

10.1016/S0140-6736(96)09124-6

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018